SCHEMBL4751000

SCHEMBL4751000

CCN(CC)CCOCCOC(=O)N1CCN(Cc2cccnc2Br)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
KDM4E B2RXH2 7/20 0.48
KMT2A Q03164 3/20 0.48
MAPT P10636 2/20 0.48
MPI P34949 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
POLB P06746 1/20 0.45
HTT P42858 2/20 0.45
MEN1 O00255 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
CTSB P07858 1/20 0.42
CHRM2 P08172 2/20 0.39
CHRM1 P11229 2/20 0.39
SLC22A1 O15245 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4751010 0.82 MAPT (0.44) ALDH1A1KDM4EKMT2AMAPTMPI
SCHEMBL4754129 0.80 KDM4E (0.50) ALDH1A1KDM4EKMT2ATDP1L3MBTL1
SCHEMBL4753147 0.80 ALDH1A1 (0.45) ALDH1A1KDM4EKMT2AMAPTMPI
SCHEMBL4753349 0.76 ALDH1A1 (0.47) ALDH1A1KDM4EKMT2AMAPTMPI
SCHEMBL4752726 0.76 POLB (0.53) ALDH1A1KDM4EKMT2AMAPTMPI
SCHEMBL30476359 0.76 POLB (0.53) ALDH1A1KDM4EKMT2AMAPTMPI
SCHEMBL4754240 0.73 KDM4E (0.50) ALDH1A1KDM4EKMT2AMAPTMPI
SCHEMBL5256033 0.70 KMT2A (0.54) ALDH1A1KDM4EKMT2AMPIL3MBTL1
SCHEMBL4805629 0.69 KDM4E (0.41) ALDH1A1KDM4ETDP1POLBHTT
SCHEMBL4750996 0.69 ALDH1A1 (0.45) ALDH1A1KDM4EKMT2AMAPTMPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008147864-A2 METHODS OF USING PIPERAZINE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-12-04 WO disclosed